CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. CTIC $6.0100 0.2200 % 3.8000 Cti Biopharm Corp Sector : Medical Industry : Medical – Drugs Signal Short Term Trend Long Term Trend BUY UP UP Day: 3.8% Wk: 5.44% Mo: […]
(Bloomberg) — The worst year for equity bulls since 2008 will also be remembered as one when the predominant investment strategies veered from one another by the most in two decades. Divergent fortunes befell the most famous U.S. stock benchmarks, with the S&P 500’s annual loss of almost 20% more than twice that of the […]